Dr. Nezam Afdhal on New HCV Agents

[jmjm530]

Informative audio tape summarizing new treatment advances including Telaprevir, R1626, Alinia and a new novel vaccine approach. Afdahl's take-away is that novel treatments (beyond SOC) are both exciting;  are improving SVR rates over SOC with less treatment time:  and that more exiting news is expected in the next 6-12 months.

For the full audio, free registration at Clinical Care Options is required  (http://www.clinicaloptions.com/)

After registering, then go to the following link and scroll down to Nezam Afdhals' Audio File:

http://www.clinicaloptions.com/Hepatitis/Conference%20Coverage/Boston%202007.aspx

[merryBe]

yeah, now if I could just get my doctor to listen to it.............

[viaduk]

Thanks for the link.  This is an exciting time for the field of HCV.  I hope that I can become more patient, and not progress any further before some of these options become available.

[scratchinghead]

Thank you!